Jeff George

Jeff George has a diverse work experience in various industries. Jeff is the Managing Partner of Maytal Capital, a healthcare-focused private equity and venture capital firm that they founded in 2017. Jeff has also served as a Board Director for Amneal Pharmaceuticals since December 2019 and for 908 Devices since February 2021. In addition, Jeff is the Chairman of MAPS Public Benefit Corporation since September 2022, where they previously served as a strategic advisor and counselor. Jeff is an Independent Board Director for Dorian Therapeutics since August 2020 and has been an Operating Partner with Revival Healthcare Capital since December 2018. Jeff is also a Partner at Bridge Builders Collaborative since August 2021 and a Board Director for WishBone Medical, Inc. from August 2020 to July 2022. Prior to their current roles, they served as a Board Director for Roam Analytics from June 2017 to October 2020 and as the CEO of Performance Health from February 2018 to December 2018.

Jeff George attended Harvard Business School from 1999 to 2001, where they obtained a Master of Business Administration (MBA). Prior to that, from 1998 to 1999, they studied at Johns Hopkins School of Advanced International Studies (SAIS), earning a Master's degree with a focus on International Economics and Emerging Markets Political Economy. During their time at SAIS, they were also recognized as a John W. Watzek Fellow and ranked in the top 10% of their class. Jeff George completed their undergraduate education at Carleton College, where they earned a Bachelor of Arts (B.A.) in International Relations. Jeff was a member of the Phi Beta Kappa honor society and graduated magna cum laude. Jeff George completed their high school education at Breck School in Minneapolis, MN, although specific dates are not provided.